Clinical Trials Directory

Trials / Conditions / Metastatic Head and Neck Carcinoma

Metastatic Head and Neck Carcinoma

9 registered clinical trials studyying Metastatic Head and Neck Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingPersonalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatmen
NCT06572423
Jonsson Comprehensive Cancer CenterN/A
Active Not RecruitingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced
NCT04514484
National Cancer Institute (NCI)Phase 1
Active Not RecruitingStudy of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide
NCT05075993
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and
NCT04140526
OncoC4, Inc.Phase 1 / Phase 2
CompletedGeriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or
NCT03902535
City of Hope Medical Center—
Active Not RecruitingPembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
NCT03468218
Emory UniversityPhase 2
CompletedRecombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
NCT03049618
University of Southern CaliforniaPhase 2
RecruitingBlood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With
NCT03010150
M.D. Anderson Cancer Center—
Active Not RecruitingThermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Co
NCT02713269
M.D. Anderson Cancer CenterPhase 2